Características clínicas de dos poblaciones diagnosticadas de enfermedad pulmonar obstructiva crónica por criterios espirométricos GOLD o por el límite inferior de la normalidad

Peces-Barba, 2008, Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC, Arch Bronconeumol., 44, 271, 10.1157/13119943 Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. www.goldcopd.com. Celli, 2004, Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, Eur Respir J., 23, 932, 10.1183/09031936.04.00014304 Celli, 2003, Population impact of different definitions of airway obstruction, Eur Respir J., 22, 268, 10.1183/09031936.03.00075102 Roberts, 2006, FEV1/FVC of 70% misclassifies patients with obstruction at the extremes of age, Chest., 130, 200, 10.1378/chest.130.1.200 Hardie, 2002, Risk of overdiagnosis of COPD in asymptomatic elderly never-smokers, Eur Respir J., 20, 1117, 10.1183/09031936.02.00023202 Enright, 2006, Does screening for COPD by primary care physicians have the potential to cause more harm than good?, Chest., 129, 833, 10.1378/chest.129.4.833 Mannino, 2007, Chronic obstructive pulmonary disease in the older adult: What defines abnormal lung function?, Thorax., 62, 237, 10.1136/thx.2006.068379 Pellegrino, 2005, Interpretative strategies for lung function tests, Eur Respir J., 26, 948, 10.1183/09031936.05.00035205 Lucas-Ramos, 2008, Asociación de factores de riesgo cardiovascular y EPOC. Resultados de un estudio epidemiológico (estudio ARCE), Arch Bronconeumol, 238, 233, 10.1157/13119937 Quanjer, 1993, Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests European Community for Steel and Coal Official Statement of the European Respiratory Society., Eur Respir J., 6, 5, 10.1183/09041950.005s1693 Scanlon, 2000, Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study, Am J Respir Crit Care Med., 161, 381, 10.1164/ajrccm.161.2.9901044 Pinto-Plata, 2007, Differences in cardiopulmonary exercise test results by American Thoracic Society/European Respiratory Society- Global Initiative for Chronic Obstructive Lung Disease stage categories and gender, Chest., 132, 1204, 10.1378/chest.07-0593 Enright, 2007, GOLD stage I is not a COPD risk factor Thorax., 62, 1107 Roche, 2008, Impact of chronic airflow obstruction in a working population Eur Respir J., 31, 1227 Ofir, 2008, Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease, Am J Respir Crit Care Med., 177, 622, 10.1164/rccm.200707-1064OC Vollmer, 2009, Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study, Eur Respir J., 34, 588, 10.1183/09031936.00164608 Mannino, 2007, Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?, Thorax., 62, 237, 10.1136/thx.2006.068379 Pistolesi, 2008, Identification of a predominant COPD phenotype in clinical practice, Respiratory Medicine., 102, 367, 10.1016/j.rmed.2007.10.019 García-Aymerich, 2009, en nombre del Grupo de Trabajo sobre la Caracterización Fenotípica y Evolución de la Enfermedad Pulmonar Obstructiva Crónica (PAC-COPD). Phenotypic heterogeneity of chronic obstructive pulmonary disease, Arch Bronconeumol., 45, 129 Rennard, 2008, The Many "Small COPDs". COPD Should be an orphan disease, CHEST., 134, 623, 10.1378/chest.07-3059 Barr, 2009, Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD, Am J Med., 122, 348, 10.1016/j.amjmed.2008.09.042 Sin, 2006, Mortality in COPD: Role of comorbidities, Eur Respir J., 28, 1245, 10.1183/09031936.00133805 Fabbri, 2008, Complex chronic comorbidities of COPD., 31, 204 Soriano, 2009, Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007, Eur Respir J Punturieri, 2008, Chronic obstructive pulmonary disease: a view from the NHLBI, Am J Respir Crit Care Med., 178, 441, 10.1164/rccm.200807-1128OE De Miguel Díez, 2005, Factors affecting drug prescription in patients with stable COPD: results from a multicenter Spanish study (IDENTEPOC), Arch Bronconeumol, 41, 63, 10.1157/13070801 Izquierdo, 2009, Study of the burden on patients with chronic obstructive pulmonary disease, Int J Clin Pract., 63, 87, 10.1111/j.1742-1241.2008.01936.x